查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1685116

肺功能測試系統市場機會、成長動力、產業趨勢分析與預測 2025 - 2034

Pulmonary Function Testing Systems Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年全球肺功能測試系統市場規模達 29 億美元，預估 2025 年至 2034 年期間複合年成長率為 6.6%。診斷技術的不斷進步、人口老化、早期疾病檢測意識的增強以及醫療保健基礎設施的改善推動了這一快速成長。隨著呼吸系統疾病變得越來越普遍，醫療保健提供者優先考慮早期診斷和有效的疾病管理，這大大增加了對先進肺功能測試系統的需求。緊湊型、高精度設備的創新使得各種醫療保健環境中的肺部評估更加容易進行。向具有成本效益和方便用戶使用的診斷工具的轉變正在塑造整個行業，推動其在臨床和家庭環境中的更廣泛應用。

肺功能測試系統市場 - IMG1

醫療技術和數位整合的持續投資進一步支持了市場成長，提高了肺部評估的效率和可靠性。對持續呼吸監測的需求日益成長，促使製造商開發具有更高功能和準確性的設備。穿戴式和遠端監控解決方案的興起正在改變呼吸診斷，使患者和醫療保健專業人員都更加方便。隨著產業走向個人化醫療，肺功能測試系統也在不斷發展，以提供更精確、更針對患者的見解。預防保健措施和廣泛的篩檢計畫正在加速應用，確保未來幾年穩步擴大。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 29億美元
預測值 54億美元
複合年成長率 6.6%

攜帶式緊湊型診斷設備由於其易於使用且能夠在各種醫療環境中提供精確的結果而受到廣泛需求。手持設備引領了市場，2024 年創造了 17 億美元的收入。這些具有成本效益的設備比大型實驗室設備更受青睞，尤其是對於需要經濟實惠但準確的呼吸評估的小型醫療機構。它們在提供即時測試方面的靈活性已在多種醫療應用中廣泛採用。隨著製造商不斷改進設備性能並提高用戶便利性，業界正在轉向數位連接和遠端監控功能。對準確且易於獲取的肺功能測試解決方案的需求不斷成長，這推動著創新，並強化了其在現代醫療保健系統中的重要作用。

慢性呼吸系統疾病是推動市場擴張的主要因素，其中慢性病佔需求的很大一部分。慢性阻塞性肺病 (COPD) 領域在 2024 年佔據了 39.8% 的市場。由於環境污染物和生活方式因素導致肺部疾病發病率上升，肺功能測試成為常規醫療保健的重要組成部分。隨著慢性呼吸系統疾病變得越來越普遍，醫療保健提供者正在投資先進的診斷設備以便於早期介入。早期檢測對於減緩疾病進展的重要性日益增加，對精確肺部評估的需求也隨之增加。檢測技術的進步正在提高效率，從而提供更好的監測和疾病管理解決方案。不斷擴大的醫療保健基礎設施也改善了人們獲得最先進肺功能測試設備的機會，從而推動了整體市場的成長。

2024 年美國肺功能測試系統市值為 13 億美元，預計到 2034 年將以 5.4% 的複合年成長率成長。作為全球醫療技術的領導者，美國繼續將高精度診斷工具整合到醫療機構中，以提高肺部評估的準確性和效率。數位和無線設備的廣泛應用進一步簡化了肺功能測試，增加了整體市場需求。憑藉對醫療保健創新的大力投資和對早期疾病檢測的日益關注，美國市場在未來十年內有望實現持續成長。

目錄

第 1 章：方法論與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業衝擊力
    • 成長動力
      • 慢性呼吸道疾病盛行率上升
      • 技術進步
      • 政府的有利舉措
    • 產業陷阱與挑戰
      • 肺功能檢測設備成本高
  • 成長潛力分析
  • 監管格局
  • 技術格局
  • 報銷場景
  • 定價分析
  • 波特的分析
  • PESTEL 分析
  • 差距分析

第4章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 策略儀表板

第5章：市場估計與預測：按產品，2021 — 2034 年

  • 主要趨勢
  • 手持式
  • 桌面

第6章：市場估計與預測：按測試類型，2021 年至 2034 年

  • 主要趨勢
  • 肺量測定
  • 運動壓力測試
  • 肺容量測試
  • 高空模擬測試
  • 氣體擴散試驗
  • 其他測試類型

第 7 章：市場估計與預測：按應用，2021 — 2034 年

  • 主要趨勢
  • 慢性阻塞性肺臟疾病
  • 氣喘
  • 慢性呼吸困難
  • 肺纖維化
  • 其他應用

第 8 章：市場估計與預測：依最終用途，2021 年至 2034 年

  • 主要趨勢
  • 醫院和診所
  • 診斷中心
  • 家庭護理設置
  • 其他最終用戶

第9章：市場估計與預測：按地區，2021 年至 2034 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第10章：公司簡介

  • Baxter
  • CHEST MI
  • COSMED
  • ECO MEDICS
  • FUKUDA SANGYO
  • GANSHORN SCHILLER GROUP
  • Geratherm Respiratory
  • medical equipment europe
  • MGC DIAGNOSTICS
  • MINATO MEDICAL SCIENCE
  • MORGAN
  • ndd Medical Technologies
  • PHILIPS
  • Vitalograph
  • Vyaire MEDICAL
簡介目錄
Product Code: 5722

The Global Pulmonary Function Testing Systems Market reached USD 2.9 billion in 2024 and is on track to expand at a CAGR of 6.6% between 2025 and 2034. This rapid growth is fueled by continuous advancements in diagnostic technologies, an aging population, increased awareness of early disease detection, and improved healthcare infrastructure. With respiratory diseases becoming more prevalent, healthcare providers are prioritizing early diagnosis and efficient disease management, which is significantly boosting the demand for advanced pulmonary function testing systems. Innovations in compact, high-precision devices are making pulmonary assessments more accessible across various healthcare settings. The shift toward cost-effective and user-friendly diagnostic tools is shaping the industry, driving greater adoption in clinical and home-based environments.

Pulmonary Function Testing Systems Market - IMG1

Market growth is further supported by ongoing investments in medical technology and digital integration, enhancing the efficiency and reliability of pulmonary assessments. The increasing need for continuous respiratory monitoring is pushing manufacturers to develop devices with improved functionality and accuracy. The rise of wearable and remote monitoring solutions is transforming respiratory diagnostics, making them more convenient for both patients and healthcare professionals. As the industry moves toward personalized medicine, pulmonary function testing systems are evolving to provide more precise and patient-specific insights. Preventive care initiatives and widespread screening programs are accelerating adoption, ensuring steady expansion in the coming years.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$2.9 Billion
Forecast Value$5.4 Billion
CAGR6.6%

Portable and compact diagnostic devices are experiencing significant demand due to their ease of use and ability to provide precise results in various healthcare environments. The handheld segment led the market, generating USD 1.7 billion in revenue in 2024. These cost-efficient devices are favored over larger, laboratory-based equipment, particularly by smaller healthcare facilities that require affordable yet accurate respiratory assessments. Their flexibility in delivering real-time testing has led to increased adoption across multiple medical applications. As manufacturers refine device performance and enhance user convenience, the industry is shifting toward digital connectivity and remote monitoring capabilities. The rising demand for accurate and accessible pulmonary function testing solutions is driving innovation, reinforcing their essential role in modern healthcare systems.

Chronic respiratory conditions are a major factor driving market expansion, with chronic diseases accounting for a substantial portion of demand. The chronic obstructive pulmonary disease (COPD) segment held a 39.8% market share in 2024. The rising incidence of pulmonary disorders due to environmental pollutants and lifestyle factors has made pulmonary function testing a crucial part of routine healthcare. As chronic respiratory diseases become more prevalent, healthcare providers are investing in advanced diagnostic equipment to facilitate early intervention. The importance of early detection in slowing disease progression is increasing demand for precise pulmonary assessments. Advancements in testing technology are improving efficiency, thus offering better monitoring and disease management solutions. Expanding healthcare infrastructure is also improving access to state-of-the-art pulmonary function testing devices, driving overall market growth.

The US pulmonary function testing systems market was valued at USD 1.3 billion in 2024 and is projected to grow at a CAGR of 5.4% through 2034. As a global leader in medical technology, the US continues to integrate high-precision diagnostic tools into healthcare institutions, improving accuracy and efficiency in pulmonary assessments. The widespread adoption of digital and wireless-enabled devices is further streamlining pulmonary function testing, increasing overall market demand. With strong investments in healthcare innovation and a rising focus on early disease detection, the US market is well-positioned for consistent growth over the next decade.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increase in prevalence of chronic respiratory diseases
      • 3.2.1.2 Technological advancements
      • 3.2.1.3 Favourable government initiatives
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost associated with pulmonary function testing devices
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
  • 3.6 Reimbursement scenario
  • 3.7 Pricing analysis
  • 3.8 Porter’s analysis
  • 3.9 PESTEL analysis
  • 3.10 Gap analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 — 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Handheld
  • 5.3 Tabletop

Chapter 6 Market Estimates and Forecast, By Test Type, 2021 — 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Spirometry
  • 6.3 Exercise stress test
  • 6.4 Lung volume test
  • 6.5 High altitude simulation testing
  • 6.6 Gas diffusion test
  • 6.7 Other test types

Chapter 7 Market Estimates and Forecast, By Application, 2021 — 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Chronic obstructive pulmonary disease
  • 7.3 Asthma
  • 7.4 Chronic shortness of breath
  • 7.5 Pulmonary fibrosis
  • 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 — 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals & clinics
  • 8.3 Diagnostic centers
  • 8.4 Homecare settings
  • 8.5 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2021 — 2034 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 Baxter
  • 10.2 CHEST M.I
  • 10.3 COSMED
  • 10.4 ECO MEDICS
  • 10.5 FUKUDA SANGYO
  • 10.6 GANSHORN SCHILLER GROUP
  • 10.7 Geratherm Respiratory
  • 10.8 medical equipment europe
  • 10.9 MGC DIAGNOSTICS
  • 10.10 MINATO MEDICAL SCIENCE
  • 10.11 MORGAN
  • 10.12 ndd Medical Technologies
  • 10.13 PHILIPS
  • 10.14 Vitalograph
  • 10.15 Vyaire MEDICAL